|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martin-Hirsch PL and Wood NJ: Cervical
cancer. BMJ Clin Evid. 2011:08182011.PubMed/NCBI
|
|
3
|
Wei LH: Prevention and treatment of
cervical cancer, it is a long-term and arduous task. Zhonghua Fu
Chan Ke Za Zhi. 48:304–306. 2013.In Chinese. PubMed/NCBI
|
|
4
|
Chaturvedi AK: Beyond cervical cancer:
Burden of other HPV-related cancers among men and women. J Adolesc
Health. 46(Suppl 4): S20–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: A review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar :
|
|
10
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng Y, Niu LL, Wei W, Zhang WY, Li XY,
Cao JH and Zhao SH: A feedback circuit between miR-133 and the
ERK1/2 pathway involving an exquisite mechanism for regulating
myoblast proliferation and differentiation. Cell Death Dis.
4:e9342013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kojima S, Chiyomaru T, Kawakami K, Yoshino
H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M, et
al: Tumour suppressors miR-1 and miR-133a target the oncogenic
function of purine nucleoside phosphorylase (PNP) in prostate
cancer. Br J Cancer. 106:405–413. 2012. View Article : Google Scholar :
|
|
14
|
Nohata N, Hanazawa T, Kikkawa N, Mutallip
M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H,
Nakagawa M, et al: Caveolin-1 mediates tumor cell migration and
invasion and its regulation by miR-133a in head and neck squamous
cell carcinoma. Int J Oncol. 38:209–217. 2011.
|
|
15
|
Cui W, Zhang S, Shan C, Zhou L and Zhou Z:
microRNA-133a regulates the cell cycle and proliferation of breast
cancer cells by targeting epidermal growth factor receptor through
the EGFR/Akt signaling pathway. FEBS J. 280:3962–3974. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiyomaru T, Enokida H, Tatarano S,
Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N
and Nakagawa M: miR-145 and miR-133a function as tumour suppressors
and directly regulate FSCN1 expression in bladder cancer. Br J
Cancer. 102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar
|
|
18
|
Dong Y, Zhao J, Wu CW, Zhang L, Liu X,
Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, et al: Tumor
suppressor functions of miR-133a in colorectal cancer. Mol Cancer
Res. 11:1051–1060. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37(Suppl 4): S9–S15. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang W, Jiang Y, Yu Q, Qiang S, Liang P,
Gao Y, Zhao X, Liu W and Zhang J: EGFR promoter methylation, EGFR
mutation, and HPV infection in chinese cervical squamous cell
carcinoma. Appl Immunohistochem Mol Morphol. Mar 16–2015.Epub ahead
of print. View Article : Google Scholar
|
|
21
|
Herbst RS: Review of epidermal growth
factor receptor biology. Int J Radiat Oncol Biol Phys. 59(Suppl 2):
S21–S26. 2004. View Article : Google Scholar
|
|
22
|
Oda K, Matsuoka Y, Funahashi A and Kitano
H: A comprehensive pathway map of epidermal growth factor receptor
signaling. Mol Syst Biol. 1:2005.00102005. View Article : Google Scholar
|
|
23
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Banno K, Iida M, Yanokura M, Kisu I, Iwata
T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer:
OncomiRs and tumor suppressor miRs in diagnosis and treatment. Sci
World J. 2014:1780752014. View Article : Google Scholar
|
|
25
|
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y,
Wang Z, Wang Z, Cheng P, Tong D, et al: MicroRNA-133a,
downregulated in osteosarcoma, suppresses proliferation and
promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 56:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moriya Y, Nohata N, Kinoshita T, Mutallip
M, Okamoto T, Yoshida S, Suzuki M, Yoshino I and Seki N: Tumor
suppressive microRNA-133a regulates novel molecular networks in
lung squamous cell carcinoma. J Hum Genet. 57:38–45. 2012.
View Article : Google Scholar
|
|
27
|
Siciliano V, Garzilli I, Fracassi C,
Criscuolo S, Ventre S and di Bernardo D: MiRNAs confer phenotypic
robustness to gene networks by suppressing biological noise. Nat
Commun. 4:23642013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang LK, Hsiao TH, Hong TM, Chen HY, Kao
SH, Wang WL, Yu SL, Lin CW and Yang PC: MicroRNA-133a suppresses
multiple oncogenic membrane receptors and cell invasion in
non-small cell lung carcinoma. PLoS One. 9:e967652014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tao J, Wu D, Xu B, Qian W, Li P, Lu Q, Yin
C and Zhang W: microRNA-133 inhibits cell proliferation, migration
and invasion in prostate cancer cells by targeting the epidermal
growth factor receptor. Oncol Rep. 27:1967–1975. 2012.PubMed/NCBI
|
|
30
|
Fukazawa EM, Baiocchi G, Soares FA,
Kumagai LY, Faloppa CC, Badiglian-Filho L, Coelho FR, Gonçalves WJ,
Costa RL and Góes JC: Cox-2, EGFR, and ERBB-2 expression in
cervical intraepithelial neoplasia and cervical cancer using an
automated imaging system. Int J Gynecol Pathol. 33:225–234. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carcereny E, Morán T, Capdevila L, Cros S,
Vilà L, de Los Llanos Gil M, Remón J and Rosell R: The epidermal
growth factor receptor (EGRF) in lung cancer. Transl Respir Med.
3:12015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu H, Yu Y, Marciniak D, Rishi AK, Sarkar
FH, Kucuk O and Majumdar AP: Epidermal growth factor receptor
(EGFR)-related protein inhibits multiple members of the EGFR family
in colon and breast cancer cells. Mol Cancer Ther. 4:435–442.
2005.PubMed/NCBI
|
